Inagaki N - Search Results

1

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group. Ohno Y, et al. Among authors: inagaki n. J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866. J Clin Endocrinol Metab. 2018. PMID: 30165444

2

Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.

Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y. Ohya M, et al. Among authors: inagaki n. Metabolism. 2005 Oct;54(10):1297-301. doi: 10.1016/j.metabol.2005.04.017. Metabolism. 2005. PMID: 16154427

3

Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men.

Mitsui R, Fukushima M, Nishi Y, Ueda N, Suzuki H, Taniguchi A, Nakai Y, Kawakita T, Kurose T, Yamada Y, Inagaki N, Seino Y. Mitsui R, et al. Among authors: inagaki n. Metabolism. 2006 Jan;55(1):53-8. doi: 10.1016/j.metabol.2005.07.006. Metabolism. 2006. PMID: 16324919 Clinical Trial.

4

Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus.

Ohgushi M, Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Ohya M, Nagasaka S, Taki Y, Yoshii S, Matsumoto K, Yamada Y, Inagaki N, Seino Y. Ohgushi M, et al. Among authors: inagaki n. Metabolism. 2007 Apr;56(4):571-7. doi: 10.1016/j.metabol.2006.12.007. Metabolism. 2007. PMID: 17379019

5

Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.

Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M. Umakoshi H, et al. Among authors: inagaki n. Clin Endocrinol (Oxf). 2015 Oct;83(4):462-7. doi: 10.1111/cen.12761. Epub 2015 Mar 16. Clin Endocrinol (Oxf). 2015. PMID: 25727719

6

Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.

Mori E, Fujikura J, Noguchi M, Nakao K, Matsubara M, Sone M, Taura D, Kusakabe T, Ebihara K, Tanaka T, Hosoda K, Takahashi K, Asaka I, Inagaki N, Nakao K. Mori E, et al. Among authors: inagaki n. Metabolism. 2016 Apr;65(4):543-56. doi: 10.1016/j.metabol.2015.12.015. Epub 2016 Jan 7. Metabolism. 2016. PMID: 26975546

7

Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.

Ueda-Sakane Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, Yasuno S, Miura M, Sone M, Yasoda A, Okada T, Togashi K, Nakao K, Inagaki N. Ueda-Sakane Y, et al. Among authors: inagaki n. Endocr J. 2016 Aug 31;63(8):703-14. doi: 10.1507/endocrj.EJ16-0038. Epub 2016 Jun 5. Endocr J. 2016. PMID: 27263854 Free article.

8

The Short-Term Impact of Dietary Counseling on Sodium Intake and Blood Pressure in Renal Allograft Recipients.

Asai K, Kobayashi T, Miyata H, Tanaka Y, Okada Y, Sakai K, Negoro H, Kamba T, Tsuji H, Shide K, Yanagita M, Inagaki N, Ogawa O. Asai K, et al. Among authors: inagaki n. Prog Transplant. 2016 Dec;26(4):365-371. doi: 10.1177/1526924816664084. Epub 2016 Sep 20. Prog Transplant. 2016. PMID: 27571851 Clinical Trial.

9

Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients With Nocturnal Polyuria.

Okumura Y, Asai K, Kobayashi T, Miyata H, Tanaka Y, Okada Y, Sakai K, Kamba T, Tsuji H, Shide K, Nagashima K, Yanagita M, Inagaki N, Ogawa O, Negoro H. Okumura Y, et al. Among authors: inagaki n. Urology. 2017 Aug;106:60-64. doi: 10.1016/j.urology.2017.04.025. Epub 2017 Apr 26. Urology. 2017. PMID: 28456542

10

Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.

Yamauchi I, Sakane Y, Fukuda Y, Fujii T, Taura D, Hirata M, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Sone M, Yasoda A, Inagaki N. Yamauchi I, et al. Among authors: inagaki n. Thyroid. 2017 Jul;27(7):894-901. doi: 10.1089/thy.2016.0562. Epub 2017 Jun 21. Thyroid. 2017. PMID: 28537531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,003 results

Search Page

Filters